IL-23 and TH17-mediated inflammation in human allergic contact dermatitis
- 1 February 2009
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 123 (2) , 486-492.e1
- https://doi.org/10.1016/j.jaci.2008.09.036
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesThe Journal of Experimental Medicine, 2007
- Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal modelThe Journal of Experimental Medicine, 2007
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007
- Phenotypic and functional features of human Th17 cellsThe Journal of Experimental Medicine, 2007
- Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9Journal of Investigative Dermatology, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact HypersensitivityThe Journal of Experimental Medicine, 1999